Cannabichromene (CBC) is a cannabinoid that is very potent, but will not make the user feel high. CBC was only discovered around 50 years ago and is one of the six different cannabinoids that are studied throughout medical research. Despite its lack of attentiveness in comparison to the other cannbinoids, it still contains fairly beneficial properties.
It was discovered in 1966 and the reason that it doesn’t cause the same euphoric effects as THC is because it doesn’t bind very well to the CB1 cannabinoid receptors in the brain. But because it does still bind to certain receptors throughout the body, it raises the body’s natural endocannbinoids. Because of its interaction with anandamide, cannabichromene is said to be a promising fighter against cancer.
One study that had tumor growth in mice observed, revealed that cannabinoids can possibly be effective in halting the tumor growth and inflammation. Because of the various studies done, CBC might just at some point in time be a chemopreventive agent. It is shown to lower the pain in arthritis patients and contain lower side effects than other drugs. In an animal study that was recently conducted, the cannabinoids had a larger emphasis on inflammation that the drugs that were used.
CBC has been proved to be beneficial for acne because it is an anti-inflammatory and inhibited some oil production in the secaceous glands. Some other conditions where CBC is effective are irritable bowel syndrome, Crohn’s disease, and neuropathy. In one study that was conducted in 2013 on mice, it showed that CBC had a positive effect on neural stem progenitor cells. These cells are important for a brain to function properly.
Use of Term
I like to use CBC instead of Alleve when my arthritis pain flares up because I don’t get the same side effects with CBC.